Similar articles

• Failure of glucagon in experimental hemorrhagic shock.

  Madden JJ Jr, Ludewig RM, Wangensteen SL. Madden JJ Jr, et al. Am J Surg. 1971 Oct;122(4):502-4. doi: 10.1016/0002-9610(71)90475-2. Am J Surg. 1971. PMID: 5098655 No abstract available.
• Hemodynamic effects of glucagon following hemorrhagic and endotoxic shock in the dog.

  Bower MG, Okude S, Jolley WB, Smith LL. Bower MG, et al. Arch Surg. 1970 Sep;101(3):411-5. doi: 10.1001/archsurg.1970.01340270059016. Arch Surg. 1970. PMID: 4914717 No abstract available.
• Hemodynamic effects of an isoquinoline derivative in the treatment of hemorrhagic shock.

  Kim SI, Nassos TP, Shoemaker WC. Kim SI, et al. J Surg Res. 1971 Aug;11(8):390-5. doi: 10.1016/0022-4804(71)90145-4. J Surg Res. 1971. PMID: 5568819 No abstract available.
• Intracoronary naloxone in hemorrhagic shock: dose-dependent stereospecific effects.

  Lechner RB, Gurll NJ, Reynolds DG. Lechner RB, et al. Am J Physiol. 1985 Aug;249(2 Pt 2):H272-7. doi: 10.1152/ajpheart.1985.249.2.H272. Am J Physiol. 1985. PMID: 4025562
• [Hemodynamic effects of nitrate derivatives (trinitrine and isosorbide dinitrate)].

  Baligadoo S, Chiche P. Baligadoo S, et al. Coeur Med Interne. 1979 Apr-Jun;18(2):271-82. Coeur Med Interne. 1979. PMID: 114352 Review. French. No abstract available.